GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, MIF, PPARA, PTGES, TBXAS1 |
10.773 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, POLB, PPARA, PTGES, SMAD3, SRC, TEK, TYR |
10.7205 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, MIF, POLA1, POLB, PPARA, SMAD3, SRC, TEK, XDH |
10.7205 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HSPA1A, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH |
9.75609 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, HSD17B2, IGF1R, INSR, POLB, PPARA, PTGES, SRC, TEK, TYR |
9.75609 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, POLB, PPARA, PTGES, SMAD3, SRC, TEK, TYR |
9.42192 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
9.34807 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
9.34656 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
9.32797 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, NUAK1, PIM1, PTGES, SMAD3, SRC, TEK, XDH |
8.62974 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, PTGES, SRC, TEK, TYR |
8.5553 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, POLA1, POLB, SMAD3, SRC |
8.555 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
8.555 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, NUAK1, PIM1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
8.35911 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGES, TBXAS1 |
7.90205 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGES, TBXAS1 |
7.64536 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, FABP3, FABP4, FUT7, MET, MIF, PPARA, PTGES, TBXAS1 |
7.6383 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.31643 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
7.29465 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
7.29465 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, NUAK1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TEK, TYR |
7.25213 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
7.14085 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, NUAK1, SRC, TEK, XDH |
7.09494 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
7.04188 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
7.00936 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
6.97745 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGES, TBXAS1 |
6.83778 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, SRC, TEK, XDH |
6.80315 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SMAD3, SRC, TEK |
6.76683 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.76683 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
6.50557 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH |
6.48547 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGES, TBXAS1 |
6.39107 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, PTGES, SRC |
6.39107 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.31601 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGES, TBXAS1 |
6.30106 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK |
6.21523 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
6.21523 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, KDR, POLB, SRC |
6.04563 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, KDR, POLB, SRC |
5.91384 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HSD17B1, HSD17B2 |
5.91384 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.86032 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.80671 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.79895 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK, TYR |
5.76526 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.76031 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD17B2, INSR, KDR, POLB, PPARA, SMAD3, SRC, TEK, TYR |
5.66015 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, F3, FABP4, KDR, MET, MIF, MMP12, PPARA, SMAD3, TEK |
5.61978 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, PPARA, SMAD3, SRC, TEK |
5.37793 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.3775 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK, TYR |
5.37146 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MIF, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.32907 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SRC, TEK, XDH |
5.23902 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGES, TBXAS1 |
5.23902 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR |
5.23902 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR |
5.23902 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, PTGES, SRC, TYR |
5.23121 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, SMAD3, SRC, TEK, XDH |
5.16133 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DRD2, DUSP3, EGFR, F3, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.14828 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP4, HSD17B2, IGF1R, INSR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TEK, TYR |
5.14786 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
5.12657 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, SMAD3, SRC, TEK |
5.12657 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
5.09226 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, NUAK1, POLA1, POLB, SMAD3, SRC |
5.00814 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.00518 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD1, DRD2, DRD3, EGFR, HSPA1A |
4.96175 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLB, SRC, TEK, XDH |
4.96021 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, MIF, PIM1, SMAD3, SRC, TEK, XDH |
4.93519 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, PPARA, SRC, TEK |
4.85569 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, DRD5, EGFR, PPARA, SMAD3 |
4.85213 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MIF, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
4.84384 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, MIF, NUAK1, SMAD3, SRC, TEK, XDH |
4.80668 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.80668 |
[BP] GO:0050801 |
ion homeostasis
|
ABCG2, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, GPR35, SMAD3 |
4.80263 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
4.78852 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.78852 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
4.74367 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.68189 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.68119 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, INSR, MIF, MMP12, SMAD3, SRC |
4.64496 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSD17B2, INSR, KDR, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
4.64394 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.57495 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, SMAD3, SRC, XDH |
4.57495 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, SMAD3, SRC, XDH |
4.56003 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, MIF, PPARA, SMAD3, TEK |
4.56003 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, MIF, SRC |
4.56003 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, KDR, MIF, SRC |
4.5544 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGES, TBXAS1 |
4.52175 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DRD2, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MIF, SRC, TEK, XDH |
4.51508 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA |
4.51508 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MIF, PIM1, SMAD3, SRC, TEK |
4.49454 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.45599 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, SMAD3, SRC |
4.45323 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC |
4.45323 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
4.42722 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD5, DUSP3, FABP4, GPR35, IGF1R, MET, PIM1, PPARA, SRC |
4.42026 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
4.39681 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MIF, PIM1, SMAD3, SRC, TEK, XDH |
4.38846 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
4.37188 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
4.37188 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, FUT7, HSD17B2, INSR, KDR, MET, MIF, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR |
4.3687 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, DRD2, DRD3, EGFR, F3, FLT3, IGF1R, INSR, KDR, MIF, MMP12, PIM1, TEK |
4.35895 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.31768 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, DRD2, EGFR, FLT3, INSR, KDR, MIF, SRC, TEK, XDH |
4.30588 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
4.30404 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F3, INSR, MET, SRC, TEK |
4.24576 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ABCG2, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, GPR35, SMAD3 |
4.22793 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, SMAD3, SRC |
4.22513 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, TYR |
4.21623 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD5, EGFR, HSPA1A, MIF, NUAK1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TEK |
4.21571 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, PIM1, PPARA, PTGES, SMAD3, SRC, TEK, XDH |
4.21571 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, FLT3, MET, MIF, PIM1, POLA1, SRC, TEK, TYR |
4.16135 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
4.15694 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.07614 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, INSR, KDR, MIF, SMAD3, SRC, TEK, XDH |
4.04493 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, INSR, KDR, MIF, SMAD3, SRC, TEK, XDH |
4.04493 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
3.96449 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.96398 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.94894 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.91217 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.90006 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.90006 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, INSR, SMAD3 |
3.90006 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, FLT3, SRC |
3.87842 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK, XDH |
3.84312 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.84312 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HSPA1A, INSR, MIF, MMP12, PPARA, SMAD3, SRC |
3.83707 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.83707 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3 |
3.8006 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
3.788 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.76105 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, DRD5 |
3.74769 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.73658 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.73658 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR |
3.72999 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, IGF1R, INSR, KDR, MET, MIF, NUAK1, POLB, SRC, TEK |
3.71529 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, DUSP3, EGFR, KDR, MIF, SRC, TEK |
3.71381 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, F3, HSPA1A, KDR, MET, MIF, MMP12, PIM1, SMAD3, SRC, TEK |
3.6955 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, MIF, MMP12, SRC |
3.62736 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, EGFR, KDR, MIF, SRC, TEK |
3.60948 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, ALPL, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, POLB, PPARA, SMAD3, SRC, TEK, TYR, XDH |
3.60678 |
[BP] GO:0055080 |
cation homeostasis
|
ABCG2, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, GPR35, SMAD3 |
3.56468 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3, DRD5 |
3.5622 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, POLB, PPARA, SMAD3, SRC, TEK |
3.54353 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.53506 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, HSD17B1, HSD17B2 |
3.53506 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, PIM1, PPARA, PTGES, SMAD3, SRC, TEK, XDH |
3.46059 |
[BP] GO:0007191 |
None
|
DRD1, DRD3, DRD5 |
3.46059 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.46059 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, INSR |
3.43333 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.39665 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, TYR |
3.38921 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
3.3878 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.3088 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, PTGES |
3.28735 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR |
3.27033 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.26797 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK, XDH |
3.23979 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA, SMAD3 |
3.23082 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MIF, PPARA, SRC, TEK, XDH |
3.20401 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR |
3.18018 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ABCG2, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, GPR35, SMAD3 |
3.1794 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC, TEK |
3.15964 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, SMAD3, SRC |
3.15964 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, DRD5, EGFR, SRC, TEK |
3.15249 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.14361 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.14361 |
[BP] GO:0060158 |
None
|
DRD1, DRD2, DRD5 |
3.14361 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, SRC |
3.12399 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC, TEK |
3.1165 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ABCG2, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, GPR35, SMAD3 |
3.10465 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.09451 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.09451 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
3.09451 |
[BP] GO:0046960 |
None
|
DRD1, DRD5 |
3.06866 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
3.05882 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
3.05882 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
3.04242 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MIF, SRC, TEK, XDH |
3.0341 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.028 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK, XDH |
3.01943 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, SMAD3, SRC, TEK |
3.01943 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
3.00503 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK, XDH |
2.99916 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, MIF, MMP12, SRC |
2.99754 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, NUAK1, SRC, TEK, XDH |
2.9913 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, PPARA, SMAD3, SRC, TEK |
2.95917 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, PPARA, SRC, TEK |
2.95917 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MIF, NUAK1, PIM1, POLB, PPARA, PTGES, SMAD3, SRC, TEK |
2.95917 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.94044 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94044 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94044 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94044 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.94044 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, F3, GPR35, HSPA1A, INSR, KDR, MET, MIF, MMP12, PIM1, SMAD3, SRC, TEK, XDH |
2.92869 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR |
2.92311 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, DRD2, DRD5, EGFR, F3, FLT3, HSPA1A, INSR, MIF, SMAD3, SRC, TEK, XDH |
2.91579 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.91579 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, PPARA, SMAD3, SRC, TEK |
2.89667 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.86706 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.84991 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.83414 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.83224 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, MMP12, SRC, XDH |
2.82866 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, SRC |
2.81961 |
[BP] GO:0019725 |
cellular homeostasis
|
ABCG2, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, GPR35, POLA1, SMAD3 |
2.79535 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.79535 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, FABP4, HSPA1A, MMP12, PPARA, SMAD3, SRC, TEK |
2.79337 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, KDR, MET, MIF, SMAD3 |
2.79216 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MIF, SRC |
2.78813 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.77277 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.77277 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.77211 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, DUSP3, HSPA1A, IGF1R, MET, MIF, SRC, XDH |
2.75723 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, PPARA, SRC |
2.75723 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ABCG2, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, GPR35, SMAD3 |
2.7522 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, SRC |
2.7522 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, TYR |
2.7522 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
2.7248 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.7248 |
[BP] GO:0007617 |
None
|
APP, DRD1, DRD5 |
2.7248 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.71997 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, SRC |
2.71286 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.7013 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, DRD2, DRD3, EGFR, MIF, MMP12, SMAD3, SRC |
2.70019 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.69311 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.69311 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.67832 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3 |
2.6735 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.6735 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.66201 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR |
2.65839 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, DRD5, EGFR, FLT3, IGF1R, INSR, SMAD3, SRC |
2.61903 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.61667 |
[BP] GO:0055065 |
metal ion homeostasis
|
ABCG2, APP, DRD1, DRD2, DRD3, DRD5, EGFR, GPR35, SMAD3 |
2.61667 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MIF, MMP12, SRC, TEK |
2.61337 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, GPR35, SMAD3 |
2.61337 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.61265 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.61231 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, DRD5, EGFR, SRC, TEK |
2.61119 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, DRD2, DRD3, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.5948 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, POLB, TYR |
2.59123 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.58442 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, MIF, PTGES |
2.5803 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, DRD2, DRD5, EGFR, F3, FLT3, HSPA1A, INSR, MET, MIF, SMAD3, SRC, TEK, XDH |
2.5662 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, PPARA, SMAD3, SRC, TEK, XDH |
2.55908 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, SRC |
2.5549 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, CYP1B1, DRD2, FABP3, HSPA1A, PTGES, SMAD3, XDH |
2.53599 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.51811 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.51811 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MET, MIF, MMP12, SRC, TEK |
2.51613 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, PTGES, SRC |
2.47546 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.47546 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.4693 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.4693 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, MIF |
2.46617 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.44863 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.44863 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.42413 |
[BP] GO:0050678 |
None
|
EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.4226 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.41536 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, EGFR, MIF, MMP12, SRC |
2.41522 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC |
2.40788 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, PPARA |
2.38492 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.38104 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.38104 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, CSNK2A1, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, KDR, MIF, SMAD3, SRC, TEK, XDH |
2.3798 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, NUAK1, SMAD3, SRC, TEK, XDH |
2.37905 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.37905 |
[BP] GO:0007189 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.37905 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, MIF, SRC |
2.37137 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.34167 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CYP1A1, DRD3, DUSP3, INSR |
2.33849 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, SRC |
2.33653 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
DRD1, DRD2, DRD3, DRD5, EGFR, KDR |
2.33653 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, MIF, MMP12, SRC |
2.33653 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DRD1, DRD5, EGFR, IGF1R, INSR, SRC |
2.3252 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD5, EGFR |
2.31644 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, GPR35, MIF |
2.31027 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MIF, MMP12, SRC, TEK |
2.30754 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.30471 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3 |
2.30471 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.30471 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.2874 |
[BP] GO:0042060 |
None
|
DRD5, EGFR, PPARA, SMAD3 |
2.28498 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, DRD3, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK |
2.28227 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.28118 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, XDH |
2.27594 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.27578 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.27578 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.27578 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.27578 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.27578 |
[BP] GO:0019098 |
None
|
APP, DRD1, DRD5 |
2.27468 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, DRD2, EGFR, MIF, MMP12, SMAD3, SRC |
2.27184 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, MIF, MMP12, SRC |
2.26619 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, SMAD3, SRC |
2.26619 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ABCG2, APP, DRD1, DRD2, DRD3, DRD5, GPR35, SMAD3 |
2.25044 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, DRD5 |
2.23929 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.23929 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.23929 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, DRD2, EGFR, FLT3, INSR, KDR, MIF, SRC, TEK, XDH |
2.21877 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, DRD3, DRD5 |
2.21559 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, MIF |
2.20753 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, TYR |
2.20753 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.20753 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, XDH |
2.20753 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, DRD5 |
2.20753 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.20753 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2 |
2.20753 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.20753 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.1691 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.1691 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, CA2, CA9, CYP1B1, DRD2, EGFR, INSR, MET, POLB, SMAD3, SRC, TEK |
2.16906 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, MIF, SRC |
2.16293 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC |
2.1472 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, XDH |
2.1472 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.14388 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.14388 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.14388 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.14388 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.14388 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.14388 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.14388 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.14388 |
[BP] GO:0046958 |
None
|
DRD1, DRD5 |
2.14388 |
[BP] GO:0040008 |
regulation of growth
|
APP, CSNK2A1, DRD2, DRD3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
2.13918 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, DRD2, EGFR, F3, FLT3, HSPA1A, INSR, KDR, MIF, SMAD3, SRC, TEK, XDH |
2.12937 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, INSR, MIF, SRC |
2.1293 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, GPR35, SMAD3 |
2.12516 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD2, MIF |
2.1225 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.12006 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, DRD2, EGFR, MIF, MMP12, SMAD3, SRC |
2.11657 |
[BP] GO:0071868 |
None
|
APP, DRD1, DRD5 |
2.11657 |
[BP] GO:0071870 |
None
|
APP, DRD1, DRD5 |
2.11657 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
FLT3, KDR, POLB, TEK, TYR |
2.11657 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, MET |
2.10637 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, XDH |
2.0945 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, DRD2, EGFR, FLT3, INSR, KDR, MIF, SRC, TEK, XDH |
2.09311 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, XDH |
2.09076 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, FABP4, PPARA, SMAD3, TEK |
2.08809 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, XDH |
2.07656 |
[BP] GO:0019933 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.07638 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CYP1A1, DRD2, DRD3, INSR |
2.0591 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, GPR35, SMAD3 |
2.0591 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.05341 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, DRD2, HSPA1A, MIF, MMP12, SMAD3, SRC |
2.04762 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, SRC |
2.04683 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
DRD2, DRD3, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, MMP12, SMAD3, SRC, XDH |
2.04194 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, SRC |
2.03919 |
[BP] GO:0050679 |
None
|
EGFR, F3, KDR, MMP12, TEK |
2.03919 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, XDH |
2.03919 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, GPR35, SMAD3 |
2.0358 |
[BP] GO:0007435 |
salivary gland morphogenesis
|
EGFR, POLB |
2.0358 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC |
2.0358 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, MIF, MMP12, SRC |
2.0358 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, SMAD3, SRC |
2.0358 |
[BP] GO:0007190 |
None
|
ADORA3, DRD1, DRD5 |
2.0358 |
[BP] GO:0032467 |
None
|
AURKB, DRD2, DRD3 |
2.0358 |
[BP] GO:0071867 |
None
|
APP, DRD1, DRD5 |
2.0358 |
[BP] GO:0071869 |
None
|
APP, DRD1, DRD5 |
2.0358 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGES |
2.0358 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD2, MIF |
2.02872 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AXL, DRD2, EGFR, MET, SRC, TEK |
2.02747 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, PPARA, SMAD3, SRC, TEK, XDH |
2.02747 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, DRD2, EGFR, FLT3, INSR, MIF, SRC, TEK |
2.0268 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, CYP1A1, DRD3, EGFR, HSPA1A, INSR, KDR, MET, MMP12, POLA1, SMAD3, SRC |
2.02289 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, SRC |
2.02289 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, SRC, TEK, TYR |
2.02102 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, F3, INSR, KDR, MIF, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
2.01983 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, MET, SMAD3, SRC |
2.01983 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, PPARA |
2.01648 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.01558 |
[BP] GO:0002686 |
None
|
ADORA1, CYP19A1, MIF |
2.01272 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CYP19A1, DRD2, DUSP3, MIF, MMP12 |
2.00533 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, TEK |
2.00533 |
[BP] GO:0016101 |
None
|
AKR1B10, CYP1A1, CYP1B1, EGFR |
2.00533 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, DRD1, DRD2, DRD3, DRD5, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
3.90514 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SRC, TEK |
3.84227 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.73658 |
[CC] GO:0044425 |
membrane part
|
ABCG2, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, FUT7, GPR35, HSD17B2, IGF1R, INSR, KDR, MET, PTGES, SRC, TBXAS1, TEK, TYR |
3.5717 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, FUT7, GPR35, HSD17B2, IGF1R, INSR, KDR, MET, PIM1, PTGES, SMAD3, SRC, TBXAS1, TEK, TYR |
3.46059 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC |
3.32329 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADORA1, CA2, CA4, CA9, DRD1, DRD2, DRD5, EGFR, INSR, MET, SRC, TEK |
3.2558 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PIM1, SMAD3, SRC, TEK |
3.23082 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.95917 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.79049 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, F3, MET, MIF, TEK |
2.63099 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, EGFR, HSD17B2, PTGES, TBXAS1 |
2.30471 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, EGFR, FLT3, HSD17B2, PTGES, TBXAS1 |
2.24996 |
[CC] GO:0097730 |
None
|
DRD1, DRD2, DRD5 |
2.1691 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APP, CA4, EGFR, HSPA1A, PTGES, SRC, TYR |
2.16014 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, PTGES, SMAD3, SRC, TBXAS1, TEK, TYR, XDH |
11.5297 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F3, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, NUAK1, PIM1, POLA1, POLB, PTGES, SRC, TBXAS1, TEK, TYR, XDH |
10.7205 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.4601 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK |
8.98952 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MMP12, PIM1, PPARA, SMAD3, TBXAS1, TYR, XDH |
8.62974 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.90205 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
7.29855 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.1777 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
7.07574 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.80315 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
6.67582 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, XDH |
6.30106 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.87939 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC, TBXAS1 |
5.78906 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.63447 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC, TBXAS1 |
5.57333 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, POLA1, PTGES, SRC, TBXAS1, XDH |
5.2867 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1, TYR |
5.23902 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
5.17696 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TYR, XDH |
5.09226 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD5 |
5.03518 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.90641 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.8972 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
4.78852 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, POLB, SRC, TEK |
4.43062 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.39384 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.25039 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
4.25039 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.16495 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
4.08499 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
4.08499 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.79662 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
3.71381 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.63223 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.58638 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, DRD5 |
3.51156 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.4728 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.44389 |
[MF] GO:0036094 |
small molecule binding
|
ABCG2, ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, XDH |
3.3831 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.23072 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PIM1, PPARA, SMAD3, SRC |
3.22326 |
[MF] GO:0043168 |
anion binding
|
ABCG2, APP, AURKB, AXL, CSNK2A1, EGFR, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGES, SRC, TEK, XDH |
3.20805 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.06866 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCG2, ADORA1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, SRC, TBXAS1, TEK, XDH |
2.95917 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MMP12, NUAK1, PIM1, POLA1, POLB, PPARA, SMAD3, TBXAS1, TYR, XDH |
2.8355 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC |
2.77274 |
[MF] GO:0005524 |
ATP binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.76349 |
[MF] GO:0000166 |
nucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, XDH |
2.69311 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK, XDH |
2.69251 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.6735 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCG2, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.64588 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCG2, ADORA1, APP, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, POLA1, SRC, TEK |
2.54408 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.51613 |
[MF] GO:0001588 |
None
|
DRD1, DRD5 |
2.44863 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.44863 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, XDH |
2.43689 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.27578 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.27468 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.14388 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, F3, HSPA1A, MET, MIF, POLA1, POLB, PPARA, SMAD3, SRC, TEK |
2.07656 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.0358 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA3 |
2.0358 |